Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Operating Expenses: 2009-2025

Historic Operating Expenses for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $140.5 million.

  • BIO-TECHNE's Operating Expenses fell 1.80% to $140.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $685.4 million, marking a year-over-year increase of 18.85%. This contributed to the annual value of $688.0 million for FY2025, which is 22.20% up from last year.
  • BIO-TECHNE's Operating Expenses amounted to $140.5 million in Q3 2025, which was down 36.92% from $222.7 million recorded in Q2 2025.
  • BIO-TECHNE's Operating Expenses' 5-year high stood at $222.7 million during Q2 2025, with a 5-year trough of $99.6 million in Q1 2021.
  • Moreover, its 3-year median value for Operating Expenses was $140.5 million (2025), whereas its average is $147.6 million.
  • As far as peak fluctuations go, BIO-TECHNE's Operating Expenses soared by 45.08% in 2021, and later decreased by 8.02% in 2023.
  • Over the past 5 years, BIO-TECHNE's Operating Expenses (Quarterly) stood at $121.3 million in 2021, then dropped by 4.84% to $115.5 million in 2022, then rose by 20.02% to $138.6 million in 2023, then rose by 5.69% to $146.5 million in 2024, then declined by 1.80% to $140.5 million in 2025.
  • Its Operating Expenses stands at $140.5 million for Q3 2025, versus $222.7 million for Q2 2025 and $175.8 million for Q1 2025.